Cary Majors Biography and Net Worth

SVP of STERIS


Cary L. Majors serves as Vice President, North American Commercial Operations. He assumed this role in April 2014. From June 2012 through April 2014 he served as Vice President, Sales & Marketing Strategy.

What is Cary L. Majors' net worth?

The estimated net worth of Cary L. Majors is at least $2.41 million as of May 13th, 2024. Mr. Majors owns 11,369 shares of STERIS stock worth more than $2,413,070 as of November 20th. This net worth evaluation does not reflect any other assets that Mr. Majors may own. Additionally, Mr. Majors receives a salary of $615,610.00 as SVP at STERIS. Learn More about Cary L. Majors' net worth.

How old is Cary L. Majors?

Mr. Majors is currently 49 years old. There are 7 older executives and no younger executives at STERIS. The oldest executive at STERIS is Ms. Julia K. Madsen, Senior Vice President of Life Sciences, who is 59 years old. Learn More on Cary L. Majors' age.

What is Cary L. Majors' salary?

As the SVP of STERIS plc, Mr. Majors earns $615,610.00 per year. There are 4 executives that earn more than Mr. Majors. The highest earning executive at STERIS is Mr. Daniel A. Carestio, President, CEO & Director, who commands a salary of $1,590,000.00 per year. Learn More on Cary L. Majors' salary.

How do I contact Cary L. Majors?

The corporate mailing address for Mr. Majors and other STERIS executives is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. STERIS can also be reached via phone at (440) 354-2600 and via email at [email protected]. Learn More on Cary L. Majors' contact information.

Has Cary L. Majors been buying or selling shares of STERIS?

Cary L. Majors has not been actively trading shares of STERIS during the last ninety days. Most recently, Cary L. Majors sold 2,024 shares of the business's stock in a transaction on Monday, May 13th. The shares were sold at an average price of $232.13, for a transaction totalling $469,831.12. Following the completion of the sale, the senior vice president now directly owns 11,369 shares of the company's stock, valued at $2,639,085.97. Learn More on Cary L. Majors' trading history.

Who are STERIS's active insiders?

STERIS's insider roster includes Richard Breeden (Director), Karen Burton (CAO), Daniel Carestio (President, CEO & Director), Cynthia Feldmann (Director), Jacqueline Kosecoff (Director), David Lewis (Director), Julia Madsen (VP), Cary Majors (SVP), Walter Rosenbrough, Jr. (CEO), Mohsen Sohi (Director), Renato Tamaro (VP), Michael Tokich (CFO), and John Zangerle (VP). Learn More on STERIS's active insiders.

Are insiders buying or selling shares of STERIS?

In the last twelve months, insiders at the medical equipment provider sold shares 5 times. They sold a total of 31,567 shares worth more than $7,674,849.84. The most recent insider tranaction occured on September, 10th when CFO Michael J Tokich sold 23,332 shares worth more than $5,763,004.00. Insiders at STERIS own 1.1% of the company. Learn More about insider trades at STERIS.

Information on this page was last updated on 9/10/2024.

Cary L. Majors Insider Trading History at STERIS

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/13/2024Sell2,024$232.13$469,831.1211,369View SEC Filing Icon  
11/15/2021Sell1,950$232.97$454,291.50View SEC Filing Icon  
11/5/2020Sell2,000$180.00$360,000.00View SEC Filing Icon  
8/10/2020Sell5,355$156.31$837,040.0522,475View SEC Filing Icon  
8/7/2019Sell5,250$152.67$801,517.50View SEC Filing Icon  
See Full Table

Cary L. Majors Buying and Selling Activity at STERIS

This chart shows Cary L Majors's buying and selling at STERIS by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

STERIS Company Overview

STERIS logo
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Read More

Today's Range

Now: $212.25
Low: $208.95
High: $213.48

50 Day Range

MA: $229.10
Low: $211.98
High: $246.48

2 Week Range

Now: $212.25
Low: $195.47
High: $248.24

Volume

754,934 shs

Average Volume

699,951 shs

Market Capitalization

$20.95 billion

P/E Ratio

48.46

Dividend Yield

1.08%

Beta

0.85